Insider Transactions in Q2 2025 at Nektar Therapeutics (NKTR)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 19
2025
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
23,208
-2.14%
|
$0
$0.67 P/Share
|
|
May 19
2025
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
9,996
-3.08%
|
$0
$0.67 P/Share
|
|
May 19
2025
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
10,712
-3.38%
|
$0
$0.67 P/Share
|